View By Speaker
M. Agronin, MD
M. Alexander, PhD, MA
S. Ancoli-Israel, Ph.D
L. Boesky, PhD
R. Brown, PhD
A. Burstein, MD
R. Dougherty, PhD
J. Draud, MD, MS
P. Earley
G. Emslie, MD
L. Ereshefsky, PharmD
M. Forstein, MD
A. Frances, MD
M. Gold, MD
D. Goodman, MD
K. Gray, MD
D. Greenberg, MD
D. Greydanus, MD
R. Hendren, DO
R. Jackson, MD
R. Jain, MD, MPH
S. Jain, PsyD, LPC, MBA
J. Kane, MD
S. Katz, MSN PMH-CNS, BC
L. Kinsella, MD, FAAN
A. Krystal, MD
S. Levine, MD
J. Maldonado, MD
V. Maletic, MD, PA
B. McCarberg, MD
J. McGough, MD, MS
L. Miller, MD
L. Nagy, MD
H. Nasrallah, MD
S. Negi, MA, PhD
J. Nelson, MD
J. Newcomer, MD
G. Papakostas, MD
M. Piasecki, MD
J. Prince, MD
Charles Raison, MD
P. Resnick, MD
A. Robb, MD
C. Rodgers, MD
M. Rosenberg, MD, PhD
J. Schim, MD
D. Schuyler, MD
S. Shea, MD
T. Simpatico, MD
T. Skale, MD
B. Smith, JD
T. Smith, MS Psych, PD, FASCP, LMHC, NCP
S. Sobel, MD
D. Sprague
M. Stein, MD, MPH
R. Stille, MBA
V. Strasburger, MD
J. Tsuang, MD
S. Verma, MD
J. Victoroff, MD, MA
J. Weiner, MD, PhD
S. Yaffe, MD
A. Young, MD, MSHS
|
Charles Raison, MDAssociate Professor
Clinical Director Mind-Body Program
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, GA
| Thursday, November 5 10:45-12:00 p.m. |
437 - Motion in Emotion: Science and Art of Bringing Physical Exercise into your Treatment Plan PD CAM 1.25 credits - Room: Mandalay Bay Ballroom CD |
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas Charles Raison, MD, Associate Professor
Clinical Director Mind-Body Program
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, GA
|
Does "Motion', that is, exercise have a place in our treatment armamentarium? This is a question all clinicians have frequently asked of themselves. The last decade of clinical and animal research has revealed surprising powerful positive effects of exercise on mood disorders. We now know that exercise affects brain volume, inflammatory cytokines, and the autonomic system. Clinical research data also points to exercise's powerful anti-depressant effects. In light of these exciting findings, this seminar is aimed at providing clinicians the research findings, as will as provide attendees with tools on how to "prescribe" exercise to their patients. Clinicians will be provided with tools to assist them in implementing an exercise prescribing program in their practices. Upon the completion of the this activity, participants will be able to: - Develop an scientifically and data based appreciation of the complex neurobiology of exercise's positive effects on on mood.
Examine the clinical, randomized data of exercise treatment in mood disorder and develop practical skills in applying this information to clinical care of patients.
|
| Sunday, November 1 02:25 - 04:05 p.m. |
TWP 110.0 - Stress, Inflammation and Mood Disorders 1.5 credits - Room: Lagoon Ballroom |
Charles Raison, MD, Associate Professor
Clinical Director Mind-Body Program
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, GA
|
Although we have grown accustomed to viewing depression as an illness of the mind, recent scientific understandings suggest that bodily processes-and especially inflammation-contribute significantly to the development and maintenance of mood disorders. An "inflammatory" view of depression also suggests that depression is not a discreet illness, but is rather a probabilistic set of symptoms that emerge from pathways that evolved to maintain adaptive homeostasis in the face of danger from predators and pathogens. This presentation explores how this new Mind-Body view unifies many currently unexplained areas in the pathophysiology and phenomenology of mood disorders in ways that have clear treatment implications. Vaccines for depression anyone? Upon the completion of this activity, participants will be able to: - Identify the relationship of inflammation, stress and mood disorders (ie, the neurobiological correlates).
- Describe the structural and functional changes that occur during the progression of stress and mood disorders.
|
| Sunday, November 1 04:45 -05:15 p.m. |
TWP 130.0 - Panel Question and Answer Session - Room: Lagoon Ballroom |
Vladimir Maletic, MD, PA, Founding Member, INEA; Clinical Professor of Neuropsyciatry and Behavioral Science, University of South Carolina School of Medicine, Columbia; Consulting Associate, Division of Child and Adolescent Psychiatry, Duke University Charles Raison, MD, Associate Professor
Clinical Director Mind-Body Program
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, GA
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas Jon Draud, MD, MS, Private Practice, Psychopharmacology and Adult Psychiatry, Heritage Medical Associates, PC; Medical Director, Psychiatry and Addiction Medicine Services, Baptist Hospital; Clinical Professor, Department of Psychology Vanderbilt University, Nashville, TN
|
Join the entire faculty of Treating the Whole Patient for an Extended Question and Answer session at the end of Day 1. |
| Monday, November 2 01:30-2:25 p.m. |
TWP 230.0 - Panel Question and Answer Session - Room: Lagoon Ballroom |
Vladimir Maletic, MD, PA, Founding Member, INEA; Clinical Professor of Neuropsyciatry and Behavioral Science, University of South Carolina School of Medicine, Columbia; Consulting Associate, Division of Child and Adolescent Psychiatry, Duke University Charles Raison, MD, Associate Professor
Clinical Director Mind-Body Program
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, GA
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas Jon Draud, MD, MS, Private Practice, Psychopharmacology and Adult Psychiatry, Heritage Medical Associates, PC; Medical Director, Psychiatry and Addiction Medicine Services, Baptist Hospital; Clinical Professor, Department of Psychology Vanderbilt University, Nashville, TN
|
Join the entire faculty of Treating the Whole Patient for an Extended Question and Answer session at the end of Day 2. |
| Wednesday, November 4 04:00-05:15 p.m. |
347 - Meditation, Inflammation and Consternation: Applying Ancient Wisdom to Mental Health in the Modern World PD CAM 1.25 credits - Room: Breakers EFKL |
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas Satya Dev Negi, MA, PhD, President, Director, Teacher and DLM Representative, Drepung Loseling Institute, Atlanta, GA Senior Lecturer, Department of Religion, Emory University Charles Raison, MD, Associate Professor
Clinical Director Mind-Body Program
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, GA
|
This is meditation's moment. From the cover of Time Magazine to the coffee table discussions of morning talk shows, meditation has acquired near mythic status both as an avenue to personal fulfillment and as a universal solvent against a dizzying array of diseases, mental and physical. However, despite increasing evidence that meditation may confer health benefits, significant gaps remain in our understanding of how meditation alters mind-body functioning to promote emotional and physical well-being. By providing a state-of-the-art update on what we do and do not know about meditation and meditation and mental health - with a focus on depression - this presentation will provide clinicians with information essential for thinking about how to incorporate meditation into their work with patients. The first talk in this program will provide an overview of research findings regarding mental health benefits of meditation, with a focus on rigorously examining areas of remaining uncertainty. The second talk will drill down deeper into a particular style of meditation - compassion meditation - to explore how this type of meditation may modulate deleterious stress responses relevant to health. The program will conclude with a chance for audience members to get a first hand sense of compassion meditation through a brief guided meditation. At the end of this program, participants should be able to: - Describe the most important unanswered research questions regarding how to best apply meditation to mental illness.
- Describe the different types of meditation practices that appear to offer the most promise as health interventions.
- Describe how meditation practices may improve central nervous system, stress and immune functioning in ways likely to benefit mental and physical disease.
- Describe what is known from the research literature regarding the effect of meditation on depression and anxiety in medically healthy and medically ill individuals.
- Describe strategies for implementing meditation into clinical practice.
|
| Wednesday, November 4 01:00 - 02:15 p.m. |
320 - Impact of Nonadherence on the Comorbid Patient: Overcoming Clinical Challenges in Psychiatric Care I 1.25 credits - Room: Mandalay Bay Ballroom IJ |
Saundra Jain, PsyD, LPC, MBA, Executive Director, Mental Health Educational Initiative, Lake Jackson, Texas Charles Raison, MD, Associate Professor
Clinical Director Mind-Body Program
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, GA
|
The session will encourage participants to explore the barriers of recognition and management of nonadherence in psychiatric patients with comorbid conditions and provide skills to balance long-term treatment requirements with optimized chronic care delivery. This activty is supported by an educational grant from Eli Lilly and Company and Bristol-Myers Squibb and Otsuka America Pharmaceuticals, Inc. This activity is sponsored by CME LLC. |
|